English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Kacie Whaley
| Sep 1, 2017
Rare disease therapy company, Shire, making executive changes
Marian Johns
| Aug 29, 2017
Shire, MircoHealth partner on app for hemophilia patients
Nicholas Gueguen
| Aug 1, 2017
Immunodeficiency disease patients report higher quality of life with CUVITRU treatment
Erianne Leatherman
| May 22, 2017
Shire outlines ADHD research at American Psychiatric Association meeting
Robert Hadley
| Apr 7, 2017
FDA accelerates review for drug that treats blood-clotting disease
Gene Johnson
| Mar 5, 2017
Shire honors Rare Disease Day with launch of 'Rare Count'
Keri Carbaugh
| Feb 17, 2017
Shire provides latest data on Hunter's syndrome, Gaucher disease
Keri Carbaugh
| Jan 8, 2017
Shire names Clark non-executive director
Trending
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily
| Jul 24, 2025
Long School of Medicine is largest physician trainer in South Texas
Patient Daily
| Jul 25, 2025
Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily
| Jul 25, 2025
Balloon sinuplasty marks 20 years since FDA approval